Kaleido Biosciences, Inc. (KLDO) [Rocket]

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	S-1/A	S-1
Revenues	1.0	0.0	0.0	21.0	7.9
Revenue growth			-100.0%	167.0%
Cost of goods sold	0.0	0.0	0.0	27.0	9.4
Gross profit	1.0	0.0	0.0	-6.0	-1.6
Gross margin	100.0%			-28.8%	-20.0%
Selling, general and administrative [+]	23.9	22.4	18.6	6.0	1.6
General and administrative	23.9	22.4	18.6	6.0	1.6
Research and development	56.0	64.2	42.1
Other operating expenses				15.0	6.3
EBITDA [+]	-77.1	-85.3	-59.9	-26.7	-9.3
EBITDA growth	-9.7%	42.5%	124.2%	186.1%
EBITDA margin	-7902.7%			-127.3%	-118.7%
Depreciation and amortization	1.8	1.3	0.8	0.3	0.1
EBIT [+]	-78.9	-86.7	-60.7	-27.0	-9.4
EBIT growth	-9.0%	42.8%	124.5%	186.5%
EBIT margin	-8089.6%			-128.8%	-120.0%
Interest expense, net [+]	2.6	-0.7	-0.1	0.4	0.1
Interest expense	2.8	1.0	1.0	0.4	0.1
Interest income	0.2	1.7	1.1	0.0
Other income (expense), net [+]	-0.2	-0.4	-1.1	-0.1	-0.1
Gain (loss) on debt retirement		-0.6
Change in fair value of warrants		0.3	-0.9
Other non-ooperating expenses	-0.2	-0.1	-0.3
Other	0.2	0.1	0.3	0.0	0.0
Pre-tax income	-81.6	-86.3	-61.7	-27.6	-9.7
Income taxes	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-81.6	-86.3	-61.7	-27.6	-9.7
Net margin	-8369.2%			-131.3%	-123.2%

Basic EPS [+]	($2.44)	($3.36)	($12.08)	($6.17)	($1.29)
Growth	-27.3%	-72.2%	95.9%	377.7%
Diluted EPS [+]	($2.44)	($3.36)	($12.08)	($6.17)	($1.29)
Growth	-27.3%	-72.2%	95.9%	377.7%

Shares outstanding (basic) [+]	33.5	25.7	5.1	4.5	7.5
Growth	30.1%	403.2%	14.3%	-40.4%
Shares outstanding (diluted) [+]	33.5	25.7	5.1	4.5	7.5
Growth	30.1%	403.2%	14.3%	-40.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.